Thursday, September 20, 2018

Animal Drug Safety Communication: FDA Alerts Pet Owners and Veterinarians About Potential for Neurologic Adverse Events Associated with Certain Flea and Tick Products


The U.S. Food and Drug Administration is alerting pet owners and veterinarians to be aware of the potential for neurologic adverse events in dogs and cats when treated with drugs that are in the isoxazoline class.

Since these products have obtained their respective FDA approvals, data received by the agency as part of its routine post-marketing activities indicates that some animals receiving Bravecto, Nexgard or Simparica have experienced adverse events such as muscle tremors, ataxia, and seizures. Another product in this class, Credelio, recently received FDA approval. These products are approved for the treatment and prevention of flea infestations, and the treatment and control of tick infestations.

The FDA is working with manufacturers of isoxazoline products to include new label information to highlight neurologic events because these events were seen consistently across the isoxazoline class of products.

See more…

Is CBD illegal? Pharmacy board says yes, but dozens of stores sell it

WLWT Cincinnati-17 hours ago
The spokeswoman for the state's Board of Pharmacy told Dykes that the agency is not taking enforcement action at this point against stores selling CBD products ...

St. Louis pharmacist admits tax, conspiracy charges

STLtoday.com-18 hours ago
ST. LOUIS • A St. Louis pharmacist pleaded guilty Tuesday to federal charges in two separate cases and admitted a role in a kickback conspiracy and also ...

Wednesday, September 19, 2018

PharMEDium says compounder misinterpreting law to compete with Endo

PharMEDium says compounder misinterpreting law to compete with ...

Reuters-8 hours ago
PharMEDium, one of the largest U.S. compounding pharmacy companies, says a smaller firm making a compounded drug that competes with Endo International ...

Keeping pharmacy in pharmacy

Australian Journal of Pharmacy (blog)-1 hour ago
In it's latest communique, the Victorian Pharmacy Authority said it, and other state and territory pharmacy registering authorities have “intervened to stop a retail ...

Very High Importance!! Doctor disciplined by California medical board for menopause therapy: The therapy Dr Hall was prescribing is known as bio-identical hormones which are extolled as a ‘safer’ alternative to traditional hormone replacement therapy.

Doctor disciplined by California medical board for menopause therapy

Infosurhoy-22 hours ago
Bioidentical hormones are synthesized in a lab and either made by major drug companies or in a compounding pharmacy, which makes personalized .

Doctor Denies Charges in Cream Scheme

WorkCompCentral-17 hours ago
A Waxahachie anesthesiologist is rejecting federal charges that he received kickbacks as part of a two-state compounding medication scheme that defrauded ...
12 hours ago - Elizabeth Rebello, Rph, M.D., FASA, was recently appointed to serve on the PharmacyCompounding Advisory Committee of the Food and Drug Administration 

From Serialization to Full Traceability: 2018 Outlook On Compliance

In just two months, pharmaceuticals entering the US pharma supply chain through drug manufacturers will be serialized according to the Drug Supply Chain Security Act(DSCSA).  It’s already been a long journey, but this is only the beginning.  Companies can’t even take a break.  In just one year the wholesale distributor saleable returns requirement will force manufacturers to either capture aggregation data or connect to a Verification Router Service (VRS)—or both!  The year after that, dispenser requirements will lead to even more verification requests coming through.  And...